Advertisement

Surgery for Liver Metastases

  • Nicola de’ Liguori CarinoEmail author
  • Luigi Bonanni
Chapter

Abstract

Life expectancy has increased significantly in recent years. Along with this even the definition of an elderly patient has been modified over the years. During the last two decades the cut-off point of 70 years became the most commonly used in literature, replacing the 65 years cut-off wider adopted in the past.

Colorectal cancer is one the most common malignant tumors in the Western world and remains the second most common cause of cancer related deaths in the United States. Up to 76% of all people affected by colorectal cancer are diagnosed between the ages of 65 and 85; and 33–50% of patients with colorectal liver metastases are 70 years old and beyond.

Over the last twenty years the number of elderly patients considered for live resection has been increasing constantly.

Nowadays, techniques in the field of hepatic surgery and peri-operative care has improved dramatically achieving mortality rates that vary between 0% and 11%, even for procedures combining colon resection with liver resection.

Recent studies published in literature showed no significant difference in postoperative complications and postoperative mortality between the age specific subgroups of patients undergoing liver resections for colorectal liver metastases. Long term survival is comparable to younger patients and a multimodality approach to metastatic disease using peri-operative chemotherapy is now established in the elderly and its use can be associated with improved results. When non resectable and only localized to the liver, colorectal liver metastases can be treated by ablative techniques such as Radiofrequency Ablation and Microwave Ablation. Such procedures, with or without the aid chemotherapy, can provide a significant improvement in overall survival.

Increasing age itself it is not a predictor of short survival therefore elderly patient affected by colorectal liver metastases should be always considered for liver resection when feasible.

Keywords

Liver metastases Colorectal metastases Liver surgery Colorectal Elderly 

References

  1. 1.
    World Health Organisation. World Health Statistics 2009. WHO Library Cataloguing-in-Publication Data. pp. 35.Google Scholar
  2. 2.
    Franceschi S, La Vecchia C. Cancer epidemiology in the elderly. Crit Rev Oncol Hematol. 2001;39(3):219–26.PubMedCrossRefGoogle Scholar
  3. 3.
    Ganz PA. Does (or should) chronologic age influence the choice of cancer treatment? Oncology. 1992;6(Suppl):45–9.PubMedGoogle Scholar
  4. 4.
    Kulik U, Framke T, Großhennig A, Ceylan A, Bektas H, Klempnauer J, Lehner F. Liver resection of colorectal liver metastases in elderly patients. World J Surg. 2011;35:2063–72.PubMedCrossRefGoogle Scholar
  5. 5.
    de Liguori Carino N, van Leeuwen BL, Ghaneh P, Wu A, Audisio RA, Poston GJ. Liver resection for colorectal liver metastases in older patients. Crit Rev Oncol Hematol. 2008;67:273–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Quaglia A, Capocaccia R, Micheli A, Carrani E, Vercelli M. A wide difference in cancer survival between middle aged and elderly patients in Europe. Int J Cancer. 2007;120:2196–201.PubMedCrossRefGoogle Scholar
  7. 7.
    Cooper GS, Yuan Z, Landefeld CS, Johanson JF, Rimm AA. A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans. Cancer. 1995;75:775–81.PubMedCrossRefGoogle Scholar
  8. 8.
    Zacharias T, Jaeck D, Oussoultzoglou E, Bachellier P, Weber JC. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg. 2004;240:858–65.PubMedCrossRefGoogle Scholar
  9. 9.
    Mitry E, Bouvier AM, Esteve J, Faivre J. Improvement in colorectal cancer survival: a population-based study. Eur J Cancer. 2005;41(15):2297–303.PubMedCrossRefGoogle Scholar
  10. 10.
    Bengtsson G, Carlsson G, Hafstrom L, Jönsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg. 1981;141:586–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18.PubMedCrossRefGoogle Scholar
  12. 12.
    Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol. 2004;22(17):3475–84.PubMedCrossRefGoogle Scholar
  13. 13.
    Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 1984;199:306–16.PubMedCrossRefGoogle Scholar
  14. 14.
    Adam R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L, Poston GJ, Wicherts DA, de Haas RJ. Liver resection of colorectal metastases in elderly patients. Br J Surg. 2010;97:366–76.PubMedCrossRefGoogle Scholar
  15. 15.
    Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006;93(4):465–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Figueras J, Ramos E, López-Ben S, Torras J, Albiol M, Llado L, González HD, Rafecas A. Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile? Clin Transl Oncol. 2007;9:392–400.PubMedCrossRefGoogle Scholar
  17. 17.
    Tocchi A, Mazzoni G, Brozzetti S, Miccini M, Cassini D, Bettelli E. Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. Int J Colorectal Dis. 2004;19(6):580–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crino L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol. 2007;25(13):1670–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94(7):982–99.PubMedCrossRefGoogle Scholar
  20. 20.
    Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–26.PubMedCrossRefGoogle Scholar
  21. 21.
    Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. 1989;9:297–301.PubMedCrossRefGoogle Scholar
  22. 22.
    Aalami OO, Fang TD, Song HM, Nacamuli RP. Physiological features of aging persons. Arch Surg. 2003;138(10):1068–76.PubMedCrossRefGoogle Scholar
  23. 23.
    Kimura F, Miyazaki M, Suwa T, Kakizaki S. Reduction of hepatic acute phase response after partial hepatectomy in elderly patients. Res Exp Med (Berl). 1996;196(5):281–90.CrossRefGoogle Scholar
  24. 24.
    Ettorre GM, Sommacale D, Farges O, Sauvanet A, Guevara O, Belghiti J. Postoperative liver function after elective right hepatectomy in elderly patients. Br J Surg. 2001;88(1):73–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Tisone G, Manzia TM, Zazza S, De Liguori Carino N, Ciceroni C, Luca De I, Toti L, Casciani CU. Marginal donors in liver transplantation. Transplant Proc. 2004;36(3):525–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Koperna T, Kisser M, Schulz F. Hepatic resection in the elderly. World J Surg. 1998;22(4):406–12.PubMedCrossRefGoogle Scholar
  27. 27.
    Menon KV, Al Mukhtar A, Aldouri A, Prasad RK, Lodge PA, Toogood GJ. Outcomes after major hepatectomy in elderly patients. J Am Coll Surg. 2006;203(5):677–83.PubMedCrossRefGoogle Scholar
  28. 28.
    Di Benedetto F, Berretta M, D’Amico G, Montalti R, De Ruvo N, Cautero N, Guerrini GP, Ballarin R, Spaggiari M, Tarantino G, Di Sandro S, Pecchi A, Luppi G, Gerunda GE. Liver resection for colorectal metastases in older adults: a paired matched analysis. J Am Geriatr Soc. 2011;59:2282–90.PubMedCrossRefGoogle Scholar
  29. 29.
    Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240(6):1052–61.PubMedCrossRefGoogle Scholar
  30. 30.
    Barone C, Nuzzo G, Cassano A, Basso M, Schinzari G, Giuliante F, D’Argento E, Trigila N, Astone A, Pozzo C. Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neo-adjuvant chemotherapy for unresectable liver metastases. Br J Cancer. 2007;97(8):1035.PubMedCrossRefGoogle Scholar
  31. 31.
    Bhagwat M, Paramesh K. Cardio-pulmonary exercise testing: an objective approach to pre-operative assessment to define level of peri-operative care. Indian J Anaesth. 2010;54(4):286–91.PubMedCrossRefGoogle Scholar
  32. 32.
    Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, Parodi S, Dal Lago D, Gioia F, Monfardini S, Aapro MS, Serraino D, Zagonel V. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494–502.PubMedCrossRefGoogle Scholar
  33. 33.
    Balducci L. Aging, frailty, and chemotherapy. Cancer Control. 2007;14(1):7–12.PubMedGoogle Scholar
  34. 34.
    Pope D, Ramesh H, Gennari R, Corsini G, Maffezzini M, Hoekstra HJ, Mobarak D, Sunouchi K, Stotter A, West C, Audisio RA. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15(4):189–97.PubMedCrossRefGoogle Scholar
  35. 35.
    Audisio RA, Zbar AP, Jaklitsch MT. Surgical management of oncogeriatric patients. J Clin Oncol. 2007;25(14):1924–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–66.PubMedCrossRefGoogle Scholar
  37. 37.
    Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES. Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer. 2009;115:752–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994;116(4):703–10.PubMedGoogle Scholar
  39. 39.
    Brunken C, Rogiers X, Malago M, Hillert C, Zornig C, Busch C, Izbicki JR, Broelsch CE. Is resection of colorectal liver metastases still justified in very elderly patients? Chirurg. 1998;69(12):1334–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Brand MI, Saclarides TJ, Dobson HD, Millikan KW. Liver resection for colorectal cancer: liver metastases in the aged. Am Surg. 2000;66(4):412–5.PubMedGoogle Scholar
  41. 41.
    Adam R, Vinet E. Regional treatment of metastasis: surgery of colorectal liver metastases. Ann Oncol. 2004;15 Suppl 4:iv103–6.PubMedGoogle Scholar
  42. 42.
    Sato M, Watanabe Y, Kashu Y, Nakata T, Hamada Y, Kawachi K. Sequential percutaneous microwave coagulation therapy for liver tumor. Am J Surg. 1998;175:322–4.PubMedCrossRefGoogle Scholar
  43. 43.
    Pathak S, Jones R, Tang JMF, Parmar C, Fenwick S, Malik H, Poston G. Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis. 2011;13:252–65.CrossRefGoogle Scholar
  44. 44.
    Rocha FG, D’Angelica M. Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol. 2010;102:968–74.PubMedCrossRefGoogle Scholar
  45. 45.
    Scott DJ, Fleming JB, Watumull LM, Lindberg G, Tesfay ST, Jones DB. The effect of hepatic inflow occlusion on laparoscopic radiofrequency ablation using simulated tumors. Surg Endosc. 2002;16:1286–91.PubMedCrossRefGoogle Scholar
  46. 46.
    Fegiz G, Ramacciato G, D’Angelo F, Barillari P, Indinnimeo M, Gozzo P, Aurello P, Valabrega S, De Angelis R. Patient selection and factors affecting results following resection for hepatic metastases from colorectal carcinoma. Int Surg. 1991;76:58–63.PubMedGoogle Scholar
  47. 47.
    Izzo F. Other thermal ablation techniques: microwave and interstitial laser ablation of liver tumors. Ann Surg Oncol. 2003;10:491–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Martin RC, Robbins K, Tomalty D, O’Hara R, Bosnjakovic P, Padr R, Rocek M, Slauf F, Scupchenko A, Tatum C. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol. 2009;7:80.PubMedCrossRefGoogle Scholar
  49. 49.
    Prompers L, Bucerius J, Brans B, Temur Y, Berger L, Felix M. Mottaghy selective internal radiation therapy (SIRT) in primary or secondary liver cancer. Methods. 2011;55:253–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Welsh J, Kennedy A. Selective internal radiation therapy for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S62–73.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.HPB UnitNorth Manchester General Hospital, Pennine Acute TrustManchesterUK

Personalised recommendations